Roth Capital Issues Pessimistic Outlook for ISPR Earnings

Ispire Technology Inc. (NASDAQ:ISPR) – Equities research analysts at Roth Capital lowered their Q3 2025 earnings estimates for shares of Ispire Technology in a research report issued to clients and investors on Tuesday, January 14th. Roth Capital analyst N. Anderson now forecasts that the company will earn ($0.11) per share for the quarter, down from their previous forecast of ($0.05). Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Ispire Technology’s current full-year earnings is ($0.24) per share. Roth Capital also issued estimates for Ispire Technology’s Q4 2025 earnings at ($0.06) EPS, FY2025 earnings at ($0.33) EPS and FY2026 earnings at ($0.12) EPS.

Separately, Roth Mkm reiterated a “buy” rating and issued a $12.50 target price on shares of Ispire Technology in a research report on Wednesday, October 2nd.

Ispire Technology Stock Performance

NASDAQ ISPR opened at $4.55 on Thursday. Ispire Technology has a one year low of $4.35 and a one year high of $12.14. The business has a fifty day moving average price of $5.68 and a 200 day moving average price of $6.52. The company has a market cap of $257.76 million, a P/E ratio of -13.38 and a beta of 2.92.

Ispire Technology (NASDAQ:ISPR) last announced its earnings results on Monday, November 11th. The company reported ($0.10) EPS for the quarter, meeting analysts’ consensus estimates of ($0.10). The business had revenue of $39.34 million during the quarter, compared to analysts’ expectations of $45.60 million. Ispire Technology had a negative return on equity of 58.50% and a negative net margin of 12.80%. During the same quarter in the prior year, the firm earned ($0.04) earnings per share.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ISPR. SG Americas Securities LLC acquired a new position in Ispire Technology during the fourth quarter worth $54,000. MetLife Investment Management LLC raised its holdings in shares of Ispire Technology by 137.6% during the 3rd quarter. MetLife Investment Management LLC now owns 11,764 shares of the company’s stock worth $73,000 after acquiring an additional 6,812 shares during the period. Zacks Investment Management acquired a new position in shares of Ispire Technology during the 3rd quarter valued at about $96,000. JPMorgan Chase & Co. grew its holdings in shares of Ispire Technology by 104.0% in the third quarter. JPMorgan Chase & Co. now owns 22,973 shares of the company’s stock valued at $143,000 after purchasing an additional 11,714 shares during the period. Finally, Barclays PLC increased its position in Ispire Technology by 311.2% during the third quarter. Barclays PLC now owns 27,461 shares of the company’s stock worth $171,000 after purchasing an additional 20,782 shares during the last quarter. 5.00% of the stock is currently owned by institutional investors and hedge funds.

About Ispire Technology

Ispire Technology Inc researches, develops, designs, commercializes, sales, markets, and distributes e-cigarettes and cannabis vaping products worldwide. The company was founded in 2019 and is based in Los Angeles, California. Ispire Technology Inc operates as a subsidiary of Pride Worldwide Investment Limited.